These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30928903)

  • 21. Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).
    Kowal-Bielecka O; Avouac J; Pittrow D; Huscher D; Behrens F; Denton CP; Foeldvari I; Humbert M; Matucci-Cerinic M; Nash P; Opitz CF; Rubin LJ; Seibold JR; Strand V; Furst DE; Distler O;
    J Rheumatol; 2011 Nov; 38(11):2419-27. PubMed ID: 21965635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of Hebrew version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument 2.0.
    Ozeri D; Peretz S; Oppenheim A; Watad A; Lidar M; Braun-Moscovici Y
    J Scleroderma Relat Disord; 2023 Feb; 8(1):31-35. PubMed ID: 36743811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
    Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Seibold JR
    Arthritis Rheum; 2001 Mar; 44(3):653-61. PubMed ID: 11263780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Delphi exercise and cluster analysis to aid in the development of potential classification criteria for systemic sclerosis using SSc experts and databases.
    Coulter C; Baron M; Pope JE
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):24-30. PubMed ID: 23557780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health-related quality of life in systemic sclerosis before and after autologous haematopoietic stem cell transplant-a systematic review.
    Puyade M; Maltez N; Lansiaux P; Pugnet G; Roblot P; Colmegna I; Hudson M; Farge D
    Rheumatology (Oxford); 2020 Apr; 59(4):779-789. PubMed ID: 31504944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups.
    Baron M; Kahaleh B; Bernstein EJ; Chung L; Clements PJ; Denton C; Domsic RT; Ferdowsi N; Foeldvari I; Frech T; Gordon JK; Hudson M; Johnson SR; Khanna D; McMahan Z; Merkel PA; Narain S; Nikpour M; Pauling JD; Ross L; Valenzuela Vergara AM; Vacca A
    J Scleroderma Relat Disord; 2019 Feb; 4(1):17-27. PubMed ID: 30906878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features.
    Hoffmann-Vold AM; Distler O; Murray B; Kowal-Bielecka O; Khanna D; Allanore Y;
    RMD Open; 2019; 5(1):e000826. PubMed ID: 30997150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician- and patient-rated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS).
    Pope J
    Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S98-111. PubMed ID: 22588774
    [No Abstract]   [Full Text] [Related]  

  • 29. Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ).
    Georges C; Chassany O; Mouthon L; Tiev K; Toledano C; Meyer O; Marjanovic Z; Heneggar C; Papo T; Crickx B; Sereni D; Cabane J; Farge D
    Clin Rheumatol; 2005 Feb; 24(1):3-10. PubMed ID: 15674652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychometric properties of the Swedish version of the Scleroderma Health Assessment Questionnaire and the Cochin Hand Function Scale in patients with systemic sclerosis.
    Hesselstrand R; Nilsson JÅ; Sandqvist G
    Scand J Rheumatol; 2013; 42(4):317-24. PubMed ID: 23442162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort.
    Nevskaya T; Baron M; Pope JE;
    Rheumatology (Oxford); 2017 Jul; 56(7):1111-1122. PubMed ID: 28340090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using Optimal Test Assembly Methods for Shortening Patient-Reported Outcome Measures: Development and Validation of the Cochin Hand Function Scale-6: A Scleroderma Patient-Centered Intervention Network Cohort Study.
    Levis AW; Harel D; Kwakkenbos L; Carrier ME; Mouthon L; Poiraudeau S; Bartlett SJ; Khanna D; Malcarne VL; Sauve M; van den Ende CH; Poole JL; Schouffoer AA; Welling J; Thombs BD;
    Arthritis Care Res (Hoboken); 2016 Nov; 68(11):1704-1713. PubMed ID: 27015290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systematic review of the epidemiology, disease characteristics and management of systemic sclerosis in Australian adults.
    Morrisroe K; Stevens W; Proudman S; Nikpour M
    Int J Rheum Dis; 2017 Nov; 20(11):1728-1750. PubMed ID: 29076640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.
    Khanna D; Furst DE; Maranian P; Seibold JR; Impens A; Mayes MD; Clements PJ; Getzug T; Hays RD
    J Rheumatol; 2011 Sep; 38(9):1920-4. PubMed ID: 21724699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of the 2017 EUSTAR activity index in an scleroderma cohort.
    Ross L; Stevens W; Wilson M; Huq M; Strickland G; Walker J; Sahhar J; Ngian GS; Roddy J; Youssef P; Proudman S; Nikpour M
    Clin Rheumatol; 2020 Dec; 39(12):3701-3705. PubMed ID: 32696281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Romanian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.
    Gorga M; Mihai C; Soare AM; Dobrotă R; Gherghe AM; Stoica V
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S61-7. PubMed ID: 26316302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis.
    White B; Bauer EA; Goldsmith LA; Hochberg MC; Katz LM; Korn JH; Lachenbruch PA; LeRoy EC; Mitrane MP; Paulus HE
    Arthritis Rheum; 1995 Mar; 38(3):351-60. PubMed ID: 7880189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trial design in scleroderma: where are we and where do we go next?
    Chung L; Denton CP; Distler O; Furst DE; Khanna D; Merkel PA;
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S97-102. PubMed ID: 22691217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index.
    Valentini G; Iudici M; Walker UA; Jaeger VK; Baron M; Carreira P; Czirják L; Denton CP; Distler O; Hachulla E; Herrick AL; Kowal-Bielecka O; Pope J; Müller-Ladner U; Riemekasten G; Avouac J; Frerix M; Jordan S; Minier T; Siegert E; Ong VH; Vettori S; Allanore Y
    Ann Rheum Dis; 2017 Jan; 76(1):270-276. PubMed ID: 27621285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of damage trajectories in systemic sclerosis using group-based trajectory modelling.
    Baron M; Barbacki A; Man A; de Vries-Bouwstra JK; Johnson D; Stevens W; Osman M; Wang M; Zhang Y; Sahhar J; Ngian GS; Proudman S; Nikpour M;
    Rheumatology (Oxford); 2023 Sep; 62(9):3059-3066. PubMed ID: 36625513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.